{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:55:10Z","timestamp":1793318110307,"version":"4.5.0"},"reference-count":21,"publisher":"Society of Nuclear Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,7,30]]},"published-print":{"date-parts":[[2025,11]]},"DOI":"10.2967\/jnumed.125.269584","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:55:19Z","timestamp":1757609719000},"page":"1743-1749","source":"Crossref","is-referenced-by-count":7,"title":["[\n                    <sup>68<\/sup>\n                    Ga]Ga-PSMA-11 PET Tumor Volume Predicts Overall Survival of Patients with Metastatic Prostate Cancer Undergoing Taxane-Based Chemotherapy"],"prefix":"10.2967","volume":"66","author":[{"given":"Stephan","family":"Beintner-Skawran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Gafita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Lorenzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Tauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Hober\u00fcck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Mattana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Di Giorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Miederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Channing J.","family":"Paller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Djaileb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilja B.","family":"Solnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Farolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ceci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Eiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew F.","family":"Voter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"2025110708450914000_66.11.1743.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"2025110708450914000_66.11.1743.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503747"},{"key":"2025110708450914000_66.11.1743.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041318"},{"key":"2025110708450914000_66.11.1743.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30314-7"},{"key":"2025110708450914000_66.11.1743.5","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001698"},{"key":"2025110708450914000_66.11.1743.6","unstructured":"Cornford P Tilki P van den Bergh RCN . EAU\u2013EANM\u2013ESTRO\u2013ESUR\u2013ISUP\u2013SIOG guidelines on prostate cancer. Presented at EAU Annual Congress; April 2024; Paris, France."},{"key":"2025110708450914000_66.11.1743.7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.2702"},{"key":"2025110708450914000_66.11.1743.8","doi-asserted-by":"crossref","first-page":"e222148","DOI":"10.1148\/radiol.222148","article-title":"Response Evaluation Criteria in PSMA PET\/CT (RECIP 1.0) in metastatic castration-resistant prostate cancer","volume":"308","author":"Gafita","year":"2023","journal-title":"Radiology."},{"key":"2025110708450914000_66.11.1743.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263072"},{"key":"2025110708450914000_66.11.1743.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266702"},{"key":"2025110708450914000_66.11.1743.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.233817"},{"key":"2025110708450914000_66.11.1743.12","unstructured":"DeepPSMA: comprehensive tumor analysis. Nucs AI website. https:\/\/www.nucs.ai\/products\/deep-psma. Accessed March 26, 2025."},{"key":"2025110708450914000_66.11.1743.13","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors","volume":"50 suppl 1","author":"Wahl","year":"2009","journal-title":"J Nucl Med."},{"key":"2025110708450914000_66.11.1743.14","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s00259-017-3887-x","article-title":"Preliminary results on response assessment using 68Ga-HBED-CC-PSMA PET\/CT in patients with metastatic prostate cancer undergoing docetaxel chemotherapy","volume":"45","author":"Seitz","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025110708450914000_66.11.1743.15","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1007\/s00259-022-06047-6","article-title":"Head-to-head comparisons of [68Ga]Ga-PSMA-11 PET\/CT, multiparametric MRI, and prostate-specific antigen for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high-risk non-metastatic prostate cancer patients: a prospective study","volume":"50","author":"Ke","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025110708450914000_66.11.1743.16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/pros.23919","article-title":"Response assessment using [68Ga]Ga-PSMA ligand PET in patients undergoing systemic therapy for metastatic castration-resistant prostate cancer","volume":"80","author":"Grubmuller","year":"2020","journal-title":"Prostate."},{"key":"2025110708450914000_66.11.1743.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264962"},{"key":"2025110708450914000_66.11.1743.18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00259-020-04934-4","article-title":"Consensus statements on PSMA PET\/CT response assessment criteria in prostate cancer","volume":"48","author":"Fanti","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025110708450914000_66.11.1743.19","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263006"},{"key":"2025110708450914000_66.11.1743.20","doi-asserted-by":"crossref","first-page":"111774","DOI":"10.1016\/j.ejrad.2024.111774","article-title":"PSMA PET\/CT for treatment response evaluation at predefined time points is superior to PSA response for predicting survival in metastatic castration-resistant prostate cancer patients","volume":"181","author":"Kleiburg","year":"2024","journal-title":"Eur J Radiol."},{"key":"2025110708450914000_66.11.1743.21","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1007\/s00259-022-06089-w","article-title":"PSMA PET\/CT: Joint EANM Procedure Guideline\/SNMMI Procedure Standard for Prostate Cancer Imaging 2.0","volume":"50","author":"Fendler","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.269584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T16:46:12Z","timestamp":1762533972000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.269584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":21,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,3]]},"published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.2967\/jnumed.125.269584"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.269584","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]}}}